(Q53286461)

English

Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy.

scientific article published in August 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Prospective validation of serum CYFRA 21-1, beta-2-microglobulin, and ferritin levels as prognostic markers in patients with nonmetastatic nasopharyngeal carcinoma undergoing radiotherapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

adaptive radiation therapy

0 references

Benny Chung-Ying Zee

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Anthony Tak-Cheung Chan

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Sing F Leungm

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Edwin P Hui

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Frankie Mo

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Wing H Kwan

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Joyce Yuen

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

0 references

publication date

1 August 2004

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

101

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

776-781

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15305409%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

21 January 2018

Expression of beta-2-microglobulin by nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

21 January 2018

Treatment strategy and clinical experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Combined chemoradiation versus radiation therapy alone in locally advanced nasopharyngeal carcinoma: results of a meta-analysis of 1,528 patients from six randomized trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Serologic markers of Epstein-Barr virus infection and nasopharyngeal carcinoma in Taiwanese men.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of Epstein-Barr virus DNA in the peripheral-blood cells of patients with nasopharyngeal carcinoma: relationship to distant metastasis and survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Strong association between hyperferritinaemia and metastatic disease in nasopharyngeal carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum levels of CYFRA 21-1 in nasopharyngeal carcinoma and its possible role in monitoring of therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of Cyfra 21-1: a potential tumor marker for non-small cell lung carcinomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive factors for success of neo-adjuvant therapy in upper gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

The clinical relevance of serum CYFRA 21-1 assay in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

The prognostic value of the tumour marker Cyfra 21-1 in carcinoma of head and neck and its role in early detection of recurrent disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Tracheal length of infants under three months old

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyfra 21-1. A new potential tumor marker for squamous cell carcinoma of head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of Cyfra 21-1 and SCC assays in head and neck tumours

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Analytical and clinical evaluation of CYFRA 21-1 by electrochemiluminescent immunoassay in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

In-depth evaluation of the AJCC/UICC 1997 staging system of nasopharyngeal carcinoma: Prognostic homogeneity and proposed refinements

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.20430

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53286461&oldid=2116062072"